Luciana Carmen Zattar-Ramos1, Regis Otaviano Franca Bezerra2, Luis Tenório de Brito Siqueira3, Marcos Roberto Menezes4, Claudia da Costa Leite5, Giovanni Guido Cerri6. 1. MD, Radiologist, Hospital Sírio-Libanês, São Paulo, SP, Brazil. 2. MD, Radiologist, Hospital Sírio-Libanês and Instituto do Câncer do Estado de São Paulo (Icesp), São Paulo, SP, Brazil. 3. MD, Radiologist, Hospital Regional de Presidente Prudente and Hospital Nossa Senhora das Graças, Presidente Prudente, SP, Brazil. 4. PhD, MD, Radiologist, Hospital Sírio-Libanês and Instituto do Câncer do Estado de São Paulo (Icesp), São Paulo, SP, Brazil. 5. Associate Professor in the Department of Radiology and Oncology of the Faculdade de Medicina da Universidade de São Paulo (FMUSP), Radiologist, Hospital Sírio-Libanês, São Paulo, SP, Brazil. 6. Full Professor in the Department of Radiology and Oncology of the Faculdade de Medicina da Universidade de São Paulo (FMUSP), Radiologist, Hospital Sírio-Libanês, São Paulo, SP, Brazil.
Abstract
A large number of gadolinium chelates have recently been tested in clinical trials. Some of those have already been approved for clinical use in the United States and Europe. Thus, new diagnostic perspectives have been incorporated into magnetic resonance imaging studies. Among such gadolinium chelates are hepatobiliary-specific contrast agents (HSCAs), which, due to their property of being selectively taken up by hepatocytes and excreted by the biliary ducts, have been widely used for the detection and characterization of focal hepatic lesions. In comparison with conventional magnetic resonance cholangiography (MRC), HSCA-enhanced MRC provides additional information, with higher spatial resolution and better anatomic evaluation of a non-dilated biliary tree. A thorough anatomic assessment of the biliary tree is crucial in various hepatic surgical procedures, such as complex resection in patients with colorectal cancer and living-donor liver transplantation. However, the use of HSCA-enhanced MRC is still limited, because of a lack of data in the literature and the poor familiarity of radiologists regarding its main indications. This pictorial essay aims to demonstrate the use of HSCA-enhanced MRC, with particular emphasis on anatomical analysis of the biliary tree, clinical applications, and the most important imaging findings.
A large number of gadolinium chelates have recently been tested in clinical trials. Some of those have already been approved for clinical use in the United States and Europe. Thus, new diagnostic perspectives have been incorporated into magnetic resonance imaging studies. Among such gadolinium chelates are hepatobiliary-specific contrast agents (HSCAs), which, due to their property of being selectively taken up by hepatocytes and excreted by the biliary ducts, have been widely used for the detection and characterization of focal hepatic lesions. In comparison with conventional magnetic resonance cholangiography (MRC), HSCA-enhanced MRC provides additional information, with higher spatial resolution and better anatomic evaluation of a non-dilated biliary tree. A thorough anatomic assessment of the biliary tree is crucial in various hepatic surgical procedures, such as complex resection in patients with colorectal cancer and living-donor liver transplantation. However, the use of HSCA-enhanced MRC is still limited, because of a lack of data in the literature and the poor familiarity of radiologists regarding its main indications. This pictorial essay aims to demonstrate the use of HSCA-enhanced MRC, with particular emphasis on anatomical analysis of the biliary tree, clinical applications, and the most important imaging findings.
Entities:
Keywords:
Biliary tree; Hepatobiliary-specific contrast agents; Magnetic resonance imaging
Gadolinium-based hepatocyte-specific contrast agents (HSCAs) allow the functional and
anatomical assessment of the biliary tract, thus facilitating the planning of
hepatobiliary surgery and the diagnosis of any associated postoperative
complications(. Hepatobiliary surgery involves
procedures of great technical difficulty. In many cases, complications related to
the biliary tract occur and can be accompanied by unexpected anatomical variations.
In liver transplantation, the rate of such complications ranges from 10% to 25%,
fatal complications occurring in up to 10% of cases(.Conventional T2-weighted magnetic resonance cholangiography (MRC) has the
disadvantage of assessing only the anatomy of the biliary tract, providing little
information in cases in which there is no dilatation. Therefore, some studies
suggest that a thorough evaluation of the biliary system involves a combination of
anatomical and functional evaluation techniques(.The HSCAs approved for clinical use in Brazil(, unlike the contrast agents routinely used in magnetic
resonance imaging, are selectively captured by functioning hepatocytes and have high
rates of elimination (of approximately 50%) through the biliary tract(. The MRC
examination protocols should be adapted for time optimization, because it is
necessary to obtain late images at 20-30 min after injection of the HSCA(.The aim of the present study was to demonstrate the use of HSCA-enhanced MRC in the
perioperative evaluation of the bile ducts. We highlight the main imaging aspects
that can inform the practice.
METHODS
We selected MRC examinations in which the HSCA gadoxetic acid
(Primovist®) was used for the perioperative assessment of the
upper abdomen in patients undergoing hepatobiliary surgery between January 2013 and
February 2015. The images were obtained from the digital archives of our
institution.
EVALUATION OF THE BILIARY ANATOMY
Anatomical variations of the biliary tract occur in approximately 30% of individuals.
The correct characterization of such variations is necessary in order to avoid
iatrogenic injuries during hepatobiliary surgery and procedures, especially in cases
of living donors for liver transplantation (Figure
1), in which accurate knowledge of the biliary anatomy is
essential(.
Figure 1
Preoperative evaluation of a liver donor candidate. The use of
HSCA-enhanced MRC allows an excellent evaluation of the normal anatomy
of the biliary tree, with delineation of the subsegmental ducts
(arrows).
Preoperative evaluation of a liver donor candidate. The use of
HSCA-enhanced MRC allows an excellent evaluation of the normal anatomy
of the biliary tree, with delineation of the subsegmental ducts
(arrows).Delineation of the biliary tree occurs in the late hepatobiliary phase of
acquisition, at 20-30 min after HSCA administration. The MRC sequences acquired with
HSCA are T1-weighted, providing images with better spatial resolution than those
obtained in the T2-weighted sequences employed in conventional
(non-contrast-enhanced MRC, especially when there is no dilatation of the bile
ducts(, as illustrated in Figure 2.
Figure 2
Preoperative evaluation for right hepatectomy in a patient with
metastatic colorectal cancer. HSCA-enhanced MRC provides excellent
delineation of the biliary tree, demonstrating an accessory bile duct in
segment VII (arrow), the recognition of which is important for the
surgical planning.
Preoperative evaluation for right hepatectomy in a patient with
metastatic colorectal cancer. HSCA-enhanced MRC provides excellent
delineation of the biliary tree, demonstrating an accessory bile duct in
segment VII (arrow), the recognition of which is important for the
surgical planning.
DIFFERENTIATION BETWEEN BILIARY AND NONBILIARY LESIONS
Making a distinction between cystic lesions near the biliary tree and those actually
within the biliary tract is important in clinical management. The presence of the
HSCA within the lumen of a cystic lesion confirms its biliary origin (Figure 3) and allows the differentiation among
choledochal cysts, pericholedochal cystic formations, diverticula, and duodenal
duplications(.
Figure 3
MRC showing a small cystic formation (arrows), adjacent to the common
hepatic duct, in a T2-weighted sequence (A) and a non-contrast-enhanced
T1-weighted in-phase sequence (B). An HSCA-enhanced T1-weighted MRC
sequence (C) unequivocally demonstrates the diagnosis of bile cyst,
after its filling with contrast (arrow).
MRC showing a small cystic formation (arrows), adjacent to the common
hepatic duct, in a T2-weighted sequence (A) and a non-contrast-enhanced
T1-weighted in-phase sequence (B). An HSCA-enhanced T1-weighted MRC
sequence (C) unequivocally demonstrates the diagnosis of bile cyst,
after its filling with contrast (arrow).
DIAGNOSIS OF ACUTE CHOLECYSTITIS
Acute cholecystitis is a common cause of acute abdomen and is initially investigated
by ultrasound. However, when the ultrasound findings are inconclusive, HSCA-enhanced
MRC can be useful, replacing scintigraphy with diisopropyl iminodiacetic acid
(DISIDA scintigraphy). A lack of HSCA uptake in the gallbladder during MRC
constitutes a specific sign of acute cholecystitis (similar to that seen in DISIDA
scintigraphy), with the additional advantage of allowing evaluation of the
differential diagnoses of abdominal pain(. It is noteworthy that the
functional evaluation is considered in combination with the other usual MRC aspects,
such as choledocholithiasis (Figure 4),
perfusion disorder (Figure 5), gallbladder
thickening, and peribiliary fluid collections(.
Figure 4
Case of choledocholithiasis. An HSCA-enhanced MRC scan shows a lack of
contrast uptake within the gallbladder (arrow).
Figure 5
Acute cholecystitis. Fast spin-echo axial T2-weighted MRC sequence (A)
demonstrating parietal thickening (arrow); non-contrast-enhanced axial
T1-weighted MRC sequence (B) showing high-protein biliary content
forming a level with a small amount of gas (arrow); and HSCA-enhanced
coronal T1-weighted MRC sequence (C) showing no contrast uptake within
the gallbladder (arrow). In such cases, the use of morphine can be
considered, although it is rarely necessary, given the set of findings
suggestive of cholecystitis.
Case of choledocholithiasis. An HSCA-enhanced MRC scan shows a lack of
contrast uptake within the gallbladder (arrow).Acute cholecystitis. Fast spin-echo axial T2-weighted MRC sequence (A)
demonstrating parietal thickening (arrow); non-contrast-enhanced axial
T1-weighted MRC sequence (B) showing high-protein biliary content
forming a level with a small amount of gas (arrow); and HSCA-enhanced
coronal T1-weighted MRC sequence (C) showing no contrast uptake within
the gallbladder (arrow). In such cases, the use of morphine can be
considered, although it is rarely necessary, given the set of findings
suggestive of cholecystitis.
DIAGNOSIS AND GRADING OF BILIARY OBSTRUCTIONS
Changes in the HSCA dynamics in the biliary tract allow the early diagnosis of
obstruction, even without evident dilatation (Figure
6), as well as allowing its classification(, as follows:
complete biliary obstruction-absence of contrast uptake in the distal and proximal
portions of a stricture or obstructive lesion (Figure
7); nearly complete biliary obstruction-contrast uptake that is
significantly late and only in the proximal portion of a stricture or obstructive
lesion; or partial biliary obstruction-contrast uptake only outside the area of the
stricture or obstructive lesion. Caution should be exercised when evaluating
patients with markedly impaired hepatic function, because the dysfunction changes
the way in which the HSCA is metabolized, reducing its uptake in the biliary tract
and simulating obstructive processes(. Early, accurate grading and characterization of
biliary obstructions is important in order to guide the therapeutic practice and,
occasionally, the surgical planning(.
Figure 6
Postoperative evaluation of a hepatectomy patient with biliodigestive
anastomosis. An HSCA-enhanced MRC scan shows late contrast uptake in the
caudate lobe (A, arrow), suggesting severe obstruction (B, arrow), even
before there was significant dilation of the biliary tree. An MRC scan
acquired three months later showed mild ectasia of the intrahepatic bile
ducts of the caudate lobe with no stricture development in the lateral
ducts of the left lobe (C, arrow).
Figure 7
HSCA-enhanced coronal T1-weighted MRC sequence acquired in the late phase
(A) showing that, despite moderate dilation of the biliary tract, there
was no elimination of contrast in the hepatobiliary phase, due to
obstruction of the distal bile duct (arrow). Non-contrast-enhanced
coronal MRC scan (B).
Postoperative evaluation of a hepatectomy patient with biliodigestive
anastomosis. An HSCA-enhanced MRC scan shows late contrast uptake in the
caudate lobe (A, arrow), suggesting severe obstruction (B, arrow), even
before there was significant dilation of the biliary tree. An MRC scan
acquired three months later showed mild ectasia of the intrahepatic bile
ducts of the caudate lobe with no stricture development in the lateral
ducts of the left lobe (C, arrow).HSCA-enhanced coronal T1-weighted MRC sequence acquired in the late phase
(A) showing that, despite moderate dilation of the biliary tract, there
was no elimination of contrast in the hepatobiliary phase, due to
obstruction of the distal bile duct (arrow). Non-contrast-enhanced
coronal MRC scan (B).
POSTOPERATIVE EVALUATION OF THE BILIARY TRACT
Iatrogenic injuries are the most common complications associated with hepatobiliary
surgery, especially performed by laparoscopy. The most common iatrogenic injuries
are fistulas, which can occur in the immediate or early postoperative period, and
strictures, which occur later(.The use of HSCA-enhanced MRC allows the diagnosis of extravasations through their
direct visualization, as well as demonstrating their origin (Figure 8). Bile duct injury is graded according to the
classification system devised by Bismuth, as well as that subsequently devised by
Strasberg(.
Figure 8
Images acquired in the hepatobiliary phase of HSCA excretion. Note the
extravasation of the contrast medium from the main duct of the lateral
segment of the left lobe (arrows).
Images acquired in the hepatobiliary phase of HSCA excretion. Note the
extravasation of the contrast medium from the main duct of the lateral
segment of the left lobe (arrows).The combination of conventional (T2-weighted) MRC and HSCA-enhanced MRC has a
reported accuracy of 84% for the detection of biliary fistulas(. Therefore, the combined use of
those two techniques increases the likelihood of the correct identification and
localization of the extravasation site (Figure
9)(.
Figure 9
Postoperative evaluation of a hepatectomy patient with biliodigestive
anastomosis. DISIDA scintigraphy suggested a liquid collection in the
anastomosis plane (A). An HSCA-enhanced MRC scan showed anastomosis
integrity and contrast accumulation in the “J” pouch (B, arrow), clearly
disproving the hypothesis of a collection or fistula.
Postoperative evaluation of a hepatectomy patient with biliodigestive
anastomosis. DISIDA scintigraphy suggested a liquid collection in the
anastomosis plane (A). An HSCA-enhanced MRC scan showed anastomosis
integrity and contrast accumulation in the “J” pouch (B, arrow), clearly
disproving the hypothesis of a collection or fistula.
DIFFERENTIAL DIAGNOSIS BETWEEN ABDOMINAL COLLECTIONS AND BILIARY FISTULAS
(BILOMAS)
Bilomas are collections of bile outside of the biliary tree. They can be spontaneous,
traumatic, or iatrogenic, the majority (70%) occurring in the upper right quadrant
of the abdomen. The accurate characterization of a biloma allows it to be
distinguished from collections of other natures, as well as informing decisions
regarding its management. A late image after HSCA administration confirms that the
collection is composed of bile and allows the site of extravasation to be
identified(. The use of MRC with a contrast agent that is specific for
biliary content allows better differentiation among abdominal collections, loculated
ascites, and cystic formations adjacent to the bile ducts (Figure 10), providing important additional information in
relation to conventional T2-weighted MRC(.
Figure 10
Collection adjacent to the hepatectomy site, which fills with contrast
medium in the hepatobiliary phase of HSCA excretion, confirming the
diagnosis of biloma (arrow).
Collection adjacent to the hepatectomy site, which fills with contrast
medium in the hepatobiliary phase of HSCA excretion, confirming the
diagnosis of biloma (arrow).
CONCLUSION
The use of HSCA-enhanced MRC is an important tool that adds functional information in
the perioperative assessment of the biliary tree and is complementary to T2-weighted
MRC(. The correct indication and interpretation of the
images can alter the clinical practice, as well as precluding the need for other
diagnostic tests, invasive procedures, biopsies, or additional
interventions(.
Authors: T Hyodo; S Kumano; F Kushihata; M Okada; M Hirata; T Tsuda; Y Takada; T Mochizuki; T Murakami Journal: Br J Radiol Date: 2012-03-14 Impact factor: 3.039
Authors: Rajan T Gupta; Christopher M Brady; Joachim Lotz; Daniel T Boll; Elmar M Merkle Journal: AJR Am J Roentgenol Date: 2010-08 Impact factor: 3.959
Authors: Nam Kyung Lee; Suk Kim; Jun Woo Lee; Suk Hong Lee; Dae Hwan Kang; Gwang Ha Kim; Hyung Il Seo Journal: Radiographics Date: 2009-10 Impact factor: 5.333